Modelling diverse sources of Clostridium difficile in the community: importance of animals, infants and asymptomatic carriers by McLure, Angus et al.
Epidemiology and Infection
cambridge.org/hyg
Original Paper
Cite this article: McLure A, Clements ACA, Kirk
M, Glass K (2019). Modelling diverse sources of
Clostridium difficile in the community:
importance of animals, infants and
asymptomatic carriers. Epidemiology and
Infection 147, e152, 1–9. https://doi.org/
10.1017/S0950268819000384
Received: 3 September 2018
Revised: 30 November 2018
Accepted: 4 February 2019
Key words:
Clostridium difficile; community-acquired
infection; hospital-acquired infection;
mathematical disease model; zoonotic
infection
Author for correspondence:
A. McLure, E-mail: angus.mclure@anu.edu.au
© The Author(s) 2019. This is an Open Access
article, distributed under the terms of the
Creative Commons Attribution licence (http://
creativecommons.org/licenses/by/4.0/), which
permits unrestricted re-use, distribution, and
reproduction in any medium, provided the
original work is properly cited.
Modelling diverse sources of Clostridium difficile
in the community: importance of animals,
infants and asymptomatic carriers
A. McLure1, A. C. A. Clements1,2, M. Kirk1 and K. Glass1
1Research School of Population Health, Australian National University, Canberra, Australian Capital Territory,
Australia and 2Faculty of Health Sciences, Curtin University, Perth, Western Australia, Australia
Abstract
Clostridium difficile infections (CDIs) affect patients in hospitals and in the community, but
the relative importance of transmission in each setting is unknown. We developed a mathem-
atical model of C. difficile transmission in a hospital and surrounding community that
included infants, adults and transmission from animal reservoirs. We assessed the role of
these transmission routes in maintaining disease and evaluated the recommended classifica-
tion system for hospital- and community-acquired CDIs. The reproduction number in the
hospital was <1 (range: 0.16–0.46) for all scenarios. Outside the hospital, the reproduction
number was >1 for nearly all scenarios without transmission from animal reservoirs (range:
1.0–1.34). However, the reproduction number for the human population was <1 if a minority
(>3.5–26.0%) of human exposures originated from animal reservoirs. Symptomatic adults
accounted for <10% transmission in the community. Under conservative assumptions, infants
accounted for 17% of community transmission. An estimated 33–40% of community-acquired
cases were reported but 28–39% of these reported cases were misclassified as hospital-acquired
by recommended definitions. Transmission could be plausibly sustained by asymptomatically
colonised adults and infants in the community or exposure to animal reservoirs, but not
hospital transmission alone. Under-reporting of community-onset cases and systematic
misclassification underplays the role of community transmission.
Introduction
Clostridiodes difficile, more commonly known as Clostridium difficile, is an emerging pathogen
that causes potentially life-threatening diarrhoea and is increasing in burden in many parts of
the world [1–3]. In the USA, it caused an estimated 453 000 infections and contributed to 29
300 deaths in 2011 [3]. C. difficile infections (CDIs) are common in healthcare facilities where
they account for 71% of hospital-associated gastrointestinal infections [4], but there is increas-
ing recognition of community-acquired cases and healthcare-acquired cases with onset of
symptoms in the community [3]. It is likely that many CDIs in the community go unreported,
either because affected people do not seek treatment [5], do not submit a stool sample when
they seek treatment [5] or their stool sample is not tested for C. difficile when submitted [6].
However, the extent of under-reporting has not known.
Colonised infants [7–10], contaminated food [11] and animals reservoirs [12] have been
identified as possible sources of C. difficile outside hospitals, however their contribution to
transmission has not been well quantified. Infants under 12 months have much higher preva-
lence of colonisation than adults [13], can be colonised for over 6 months by a single strain [7]
and rarely develop symptoms but shed the same density of spores in their faeces as adults with
CDI [8]. However, existing models of C. difficile do not capture infant colonisation or their
potential role in transmission. Some strains of toxigenic C. difficile that cause disease in
humans are also isolated from livestock, meat and fresh produce contaminated by animal fae-
ces [11, 12]. However, the proportion of human cases that are acquired from food or animals
and the ramifications for disease control are unknown.
The Infectious Disease Society of America (IDSA) and the Society for Healthcare
Epidemiology of America (SHEA) recommend that CDI cases be classified as community-
acquired or hospital-acquired according to time between onset of symptoms and most recent
hospital admission or discharge [14]. Though the recommended system is not evidence-based
[14], the system and minor variants are widely used to estimate the incidence of hospital- and
community-acquired cases in the USA and many other countries [2, 3, 15, 16]. The recom-
mended classification system has been shown to incorrectly classify many CDIs amongst hos-
pitalised patients, underestimating the proportion of cases acquired prior to hospitalisation
[17]. However, there has been no published assessment of the full classification system as
applied to hospital-onset and community-onset cases.
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Despite the importance of the community as both a source of
new infections and the location of onset for some healthcare-
associated infections, there is to date only one published model
of C. difficile transmission that explicitly models patients outside
hospitals [18]. The same model estimates an upper bound to the
transmission from food and animals but does not explore the con-
sequences of animal exposure as a source of C. difficile transmis-
sion. There have been no models that include the potentially
important role of infants. We developed a model of C. difficile
transmission in hospitals and communities to explore the contri-
butions of hospitals, communities, adults, infants, animals and
food to the transmission of toxigenic C. difficile in human popu-
lations. We also estimated the extent of under-reporting in the
community and assessed the commonly used definitions of
hospital- and community-acquired CDI.
Methods
Model structure
We adapted a compartmental model of toxigenic C. difficile trans-
mission in hospitals [19] to model transmission in a hospital and
the surrounding community, adding treatment seeking, compart-
ments for infants under 12 months, demographic processes, wan-
ing immunity and transmission from animal reservoirs. The
model of the non-infant population had the same structure in
both the hospital and community, with non-infants distributed
amongst different compartments according to their immunity
to C. difficile toxins, C. difficile colonisation state and the state
of their gut flora. However, antibiotic prescription rates and
treatment-seeking behaviour differed between the hospital and
community while infants were only modelled in the community.
The structure is summarised in Figure 1 and Figure S1.
Non-infants (whom we call adults from here on) had three
immune statuses: able to mount an effective immune response to
C. difficile toxins conferring resistance or immunity to symptoms
but not colonisation; naive to C. difficile toxins but with a healthy
immune system; and unable to mount an effective immune
response to C. difficile toxins because of advanced age or a sup-
pressed immune system. Immunity could be conferred to any non-
suppressed adult by either extended asymptomatic carriage or
recovery from CDI. Any immune person could have their immun-
ity wane when they are not colonised and any non-suppressed
individual (including infants) could age to become suppressed.
There were two possible commensal gut flora statuses for
adults: disrupted and not disrupted. There were four possible C.
difficile statuses: free of C. difficile, colonised, C. difficile over-
growth without treatment and C. difficile overgrowth with treat-
ment. As we were concerned primarily with strains that can
cause symptomatic disease, we only modelled toxigenic strains
of C. difficile. An individual could have almost any combination
of gut flora and C. difficile statuses, but we assumed that C. diffi-
cile overgrowth could only occur in individuals with disrupted gut
flora. Non-immune adults with C. difficile overgrowth were con-
sidered symptomatic, while all other colonised individuals
(infants, immune adults and adults without C. difficile over-
growth) were considered asymptomatic. Both symptomatic and
asymptomatically colonised individuals shed spores and so were
infectious [20]. Spore shedding has been observed to increase
before toxin production [21], but decrease during C. difficile treat-
ment [22]. Therefore, asymptomatically colonised individuals
with disrupted gut flora and individuals with overgrowth were
equally infectious, patients receiving treatment had reduced infec-
tiousness determined by the effectiveness and coverage of contact
precautions [19] and colonised patients with intact gut flora trans-
mitted at a reduced rate.
Since CDI is only rarely observed in infants under 12 months
and antibiotics do not predispose infants to carriage [10], the
model for infants was much simpler than for adults, consisting
of only three compartments. At birth, infants were not colonised
[8, 9] and did not have immunity [23]. As with adults, colonisa-
tion conferred immunity, but for simplicity we assumed this
occurred immediately so there was no colonised-but-not-immune
class for infants. Infants could clear their colonisation [8, 9].
Infants aged by entering the corresponding adult class with intact
gut flora that shared the same colonisation and immune states.
Model parameterisation
Many of the parameters used in this model were based on our
previous model of C. difficile transmission in hospitals [19]
and/or drawn from the literature (Table S1). Eight parameters
were fitted to data in this study. The likelihood function used to
fit the model was composed from data for the prevalence of col-
onisation [9] and immunity [23] at given ages, longitudinal infant
colonisation [8, 9], the proportion of hospital admissions with
CDI as the primary diagnosis [24] and the incidence of reported
hospital- and community-acquired cases [3]. The reported esti-
mates of the prevalence of toxigenic colonisation in the general
adult population have varied considerably between settings and
studies. These studies have used different detection methods
and often had small sample sizes [13]. Therefore, we considered
multiple scenarios with colonisation prevalence from the range
2–10%, with a default of 5%. We determined the values of the
eight parameters that (A) ensured that a predetermined propor-
tion (in the range 2–10%) of the general adult population was
colonised and (B) maximised the model likelihood. This was
repeated for a range of values of the colonisation prevalence in
the general adult population. See Supplementary materials for
details of all parameters and how they were estimated.
Transmission from infants
Despite their high carriage rates, there has been little research on
the contribution of infants to C. difficile transmission.
Furthermore, the relative infectiousness of infants and adults in
the community cannot be determined using our model and avail-
able data. It has been shown that the mean density of C. difficile
per gram of stool is similar for asymptomatically colonised infants
and adults with CDI [8]. However, many other unquantified fac-
tors (e.g. hygiene practices and the number of social contacts)
contribute to infectiousness, so we considered a wide range of
assumptions in our sensitivity analysis. In a preliminary analysis,
model fit was poor and/or the proportion of transmission from
infants implausibly high in scenarios where infant infectiousness
exceeded that of symptomatic adults. Therefore, we considered
relative infant infectiousness in the range 0–1 for our sensitivity
analysis with 0.5 as conservative default assumption.
Accounting for under-reporting and misclassification of CDIs
To fit our model to incidence estimates for CDI [3], we simulated
the processes of treatment seeking, reporting and the classification
of cases as hospital or community-acquired. We assumed that, as
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with other diarrhoeal diseases, some patients recover from CDI
without seeking treatment [25], by modelling treatment seeking
in the community and recovery as competing hazards (see
Supplementary materials for details). To account for the low
testing rate for diarrhoea in general [5, 25] and community-onset
CDI in particular [6], we estimated the proportion of cases seek-
ing treatment in the community that were identified, allowing us
to compare model outputs to published estimates of disease bur-
den based on notification data [3].
The IDSA and SHEA recommend surveillance definitions that
classify where a CDI was acquired by location of onset of symp-
toms (healthcare facility or community) and by time since the
most recent hospital discharge or admission [14] (Fig. 2). Lessa
et al. [3] employed a variant of these definitions to estimate the
incidence of initial (i.e. non-recurrent) hospital- and community-
acquired CDIs in the USA (Fig. 2). We therefore emulated this
classification system to fit our model to the incidence of hospital-
and community-acquired CDIs reported by Lessa et al. (see
Supplementary materials for further details).
To determine the true origin of an infection in our model, we
subdivided each C. difficile-positive compartment into hospital-
acquired and community-acquired compartments, allowing us
to track where infection was acquired even if patients moved
between settings once or more between acquisition and onset of
symptoms. For simplicity, we assumed that current hospital-
acquired colonisation prevented community-acquired colonisa-
tion and vice versa. This assumption had no effect on overall
transmission dynamics. Moreover, coinfection with multiple
strains (which may have been acquired from multiple sources)
accounts for only approximately 10% of infections [26], so our
simplifying assumption was unlikely to substantially affect the
classification of infections. For each set of surveillance definitions,
we calculated the sensitivity and precision to identify hospital-
and community-acquired cases amongst both hospital-onset
and reported community-onset cases, using the true origin of
infection in our model as a gold standard. We identified cut-offs
that improved on the existing definitions amongst reported cases,
considering classification systems with a single cut-off for time
since hospital admission and a single cut-off for time since
most recent hospital discharge (i.e. classifying no cases as indeter-
minate). The balanced pair of cut-offs had equal sensitivity to
identify hospital- and community-acquired cases amongst both
hospital-onset cases and community-onset cases. The optimal
pair of cut-offs had equal precision and sensitivity when identify-
ing hospital-acquired cases, amongst both hospital-onset and
community-onset cases.
Reproduction number
Since the extent of human exposure to animal reservoirs of C. dif-
ficile is unknown, we calculated reproduction numbers assuming
that all exposure was due to person-to-person transmission – an
upper bound for the true reproduction number. We calculated the
reproduction number for the whole population. We also calcu-
lated reproduction numbers for the community and the hospital
separately. The latter calculations were identical to standard next-
generation matrix calculations [27], except we only considered the
colonised individuals in the setting of interest to be colonised for
the purposes of the calculation. The reproduction numbers for
hospital and community were the endemic threshold parameters
in each setting assuming no external sources of C. difficile (move-
ment of patients or animal reservoir).
Food- and animal-driven transmission
The extent of zoonotic or foodborne C. difficile exposure is
unknown; however, we considered the implications of differing
amounts transmission from animal reservoirs. For a given force
of colonisation, higher human exposure from food or animals
implies less person-to-person transmission and therefore a smal-
ler reproduction number. If a sufficient proportion of exposure
originates from food or animals, the reproduction number in
the human population is less than one and human disease is sus-
tained by constant exposure to non-human sources of C. difficile.
In this case, we say that C. difficile is animal-driven.
For each set of modelling assumptions, we calculated the
extent of foodborne exposure that implied C. difficile was animal-
driven. We expressed this animal-driven threshold in terms of
exposures leading to colonisation per person per year and as a
proportion of all transmission (i.e. foodborne transmission and
person-to-person transmission).
Fig. 1. Model structure showing including colonisation, gut flora status, symptoms and treatment. Adults in the immune classes do not have symptoms and there-
fore not all individuals with overgrowth seek or receive treatment (dashed arrows and box). The details for infants, immunity, demographics and hospital–com-
munity structure are summarised in Figure S1. The definitions and values of the parameters associated with each transition can be found in Table S1. †The force of
colonisation depends in the number and type of infectious individuals in the same setting (hospital or community).
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Results
Model fit
Themodel fitted the datawell, reproducing the observed age profile
of toxigenic C. difficile colonisation, immunity, reported incidence
of infection and proportion of admissions for CDI (Figure S2). For
most scenarios, infant infectiousness did not affect model fit.
However, the model fit was poor for combinations of low colonisa-
tion prevalence amongst adults and high infant infectiousness, so
these scenarios were not considered further. Themodel was verified
by outcomes not used to fit the model such as recurrence propor-
tion for hospital and community cases, the proportion of hospital-
based transmission attributable to symptomatic carriers, the
duration of colonisation in infants and the greater proportion of
elderly and immune suppressed in hospital-acquired vs.
community-acquired cases (see Supplementary materials for
details). In our model, colonisation prevalence was 17% higher
(range: 4–55%) at hospital discharge than in the general adult
population, agreeing with the common observation that colonisa-
tion is more common amongst those who have been recently
discharged from hospital. However, 78% (range: 60–87%) of colo-
nised discharges had acquired the pathogen in the community
prior to admission and remained colonised for the duration of
their hospital stay. We estimated a mean immune period of 9.4
years (range: 4.0–30.4 years) with the longest immune period
when we assumed adult colonisation prevalence was low (2%).
Reproduction number and food-driven threshold
Under the assumption of no foodborne transmission, the reproduc-
tion number for the whole population was greater than one for all
plausible assumptions (default: 1.11, range: 1.03–1.35) (Fig. 3a).
The reproduction number for the hospital was less than one for
all plausible assumptions (default: 0.28, range: 0.16–0.46), decreas-
ing with increasing colonisation prevalence of adults in the commu-
nity and unaffected by assumptions concerning the infectiousness
of infants (Fig. 3c). The reproduction number for the community
was close to but lower than the reproduction number for the
whole population (default: 1.09, range: 0.999–1.34) (Fig. 3b) and
increased with increasing infant infectiousness. The reproduction
number was less than one in the community only if infants were
not infectious and adult colonisation prevalence was 2%.
The animal-driven threshold (the minimum force of colonisa-
tion attributable to food and animals that implies the reproduc-
tion number in the human population is less than one), was
0.046 exposures per person per year (range: 0.006–0.107) or
10.6% of all transmission in the community (range: 3.5–26.0%)
(Fig. 4). This is equivalent to one foodborne or animal exposure
Fig. 2. The classification of CDI cases based on IDSA and SHEA surveillance recommendations that we assessed with our model. Lessa et al. used a similar clas-
sification scheme to estimate incidence in the USA. *Lessa et al. used a 12-week cut-off and therefore do not classify any cases as ‘indeterminate’. ‡Lessa et al. used
a 3-day cut-off. †We used symptom onset or hospital admission as reference points in our simulations. However, the classification system recommended by IDSA
and SHEA uses onset of symptoms as the reference point for all cut-offs. Our classification is otherwise identical. Lessa et al. used date of positive faecal sample as
reference point.
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leading to colonisation every 21.7 years per person (range 9.4–
175.5 years). The animal-driven threshold was lowest (once
every 175.5 years per person) if infants were not infectious and
adult colonisation prevalence was low (2%). The animal-driven
threshold was highest (once every 9.4 years per person) if infants
were as infectious as adults and adult colonisation prevalence was
high (10%). The model had poor model fit at the animal-driven
threshold when infant infectiousness was high and adult colonisa-
tion prevalence was low.
Transmission from infants and asymptomatic adults with
intact gut flora
In our main analysis, 13–30% of transmission in hospitals was
from patients receiving treatment for CDI, but <10% of all
transmission in the community was attributable to symptomatic
patients or patients with disrupted gut flora. The remaining trans-
mission was attributable to infants or asymptomatically colonised
adults with intact gut flora. The proportion of transmission in the
community attributable to infants was 17.4% for our conservative
default scenario but was highly sensitive to the relative infectious-
ness of infants and colonisation prevalence in adults (Figure S3).
With infants as infectious as symptomatic adults and adult colon-
isation prevalence in the community at ⩽5%, ⩾40% of transmis-
sion in the community was attributable to infants. The proportion
of transmission attributable to asymptomatically colonised indivi-
duals with intact gut flora was also highly sensitive to these
assumptions (Figure S4). Under default assumptions, this group
accounted for 79% of transmission in the community and 25%
of transmission in the hospital, but ⩾90% of transmission in
Fig. 3. The reproduction number at the disease-free equilibrium for various plausible assumptions for the colonisation prevalence in adults and relative infectious-
ness of infants for (a) the whole population, (b) the community only and (c) the hospital only. The model had poorer model fit for the combination of high infant
infectiousness and low adult colonisation prevalence, so these combinations are omitted from the figures.
Fig. 4. The animal-driven threshold under various plausible assumptions for the C. difficile colonisation prevalence in adults, and the relative infectiousness of
infants as (a) a proportion of all transmission in the community and (b) as rate of exposure to adults in the community. The reproduction number is less than
one in the community if transmission from animals exceeds the animal-driven threshold. The model had poorer model fit at the animal-driven threshold for
the combination of high infant infectiousness and low adult colonisation prevalence, so these combinations are omitted from the figures.
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the community if colonisation prevalence was 10% amongst
adults in the community. Patients with CDI and colonised indivi-
duals with disrupted gut flora were 6.6 times more infectious
(range: 2.8–131.8) than colonised individuals with intact gut
flora, but were much less numerous, especially in the community
where the antibiotic prescription rate was low. Infants cleared
their colonisation 9.2–11.5 times more slowly than adults with
intact gut flora. Under most scenarios, infants were also more
exposed or susceptible to colonisation (default: factor of 1.4;
range: 0.6–4.4) and more infectious (default: factor of 3.3;
range: 0–9.8) than asymptomatic adults with intact gut flora
(compare Table 1 and Table S1).
Under-reporting and misclassification of CDIs
Though we estimated that patients with CDI were admitted to
hospital at 59 (range: 53–73) times the rate of the general adult
population (Table 1), only 48% of adults with community-onset
CDIs sought treatment in the community or hospital (Table 2)
and only 63% (range 56–76%) of CDIs treated in the community
were reported (Table 1). Therefore, while we assume that 100% of
symptomatic hospital-onset infections were reported, we estimate
that only 30% (range 27–37%) of all community-onset CDIs were
reported. Considering both hospital- and community-onset CDIs,
only 67% (range 66–70%) of all hospital-acquired CDIs and 35%
(range 33–40%) of all community-acquired cases were reported
(Table 2).
Standard CDI classification schemes misclassified many of the
reported community-acquired cases as hospital-acquired in our
model: 63% (range: 43–76%) of cases classified as hospital-acquired
with the IDSA/SHEA scheme were actually community-acquired
(Table 2). The classification systems were much more precise but
less sensitive for community-acquired cases (Table 2). Though
total incidence was underestimated due to under-reporting, both
classification schemes overestimated the proportion of reported
cases that were hospital-acquired (Fig. 5). We estimate that
only 40% (range: 26.5–60.6%) of hospital-onset and 4.5%
(range: 2.7–8.4%) of reported community-onset infections are
hospital-acquired. In contrast, the classification scheme recom-
mended by IDSA and SHEA classified 89.6% (range: 88.9–90.3%)
Table 1. Definitions, values and references for eight parameters fitted with the model
Parameter Description
Value
(Sensitivity analysis range)
σ Rate at which immunity wanes 2.9 × 10−4 (0.9–6.9 × 10−4)
θ Multiplicative factor for colonisation susceptibility of infants 1.4 (0.6–4.4)
γinfant Rate at which C. difficile is cleared in infants 2.0 × 10
−3 (2.0–2.5 × 10−3)
pdisrupt Proportion of antibiotics that disrupt gut flora 0.22 (0.12–0.48)
preport Proportion of all community-treated CDIs that are reported 0.63 (0.57–0.76)
νCDI Hospital admission rate for CDI 1.4 × 10
−2 (1.3–1.7 × 10−2)
βDisrupt Transmission rate coefficient for colonised adults with disrupted gut flora (due to recent antibiotic
exposure)
12.8 × 10−2 (7.1–17.4 × 10−2)a
βIntact Transmission rate coefficient for colonised adults with intact gut flora (no recent antibiotic exposure) 1.9 × 10
−2 (0.1–2.6 × 10−2)a
βinfant Transmission rate coefficient from infants 6.4 × 10
−2 (0–17.4 × 10−2)a
A full list of parameters can be found in Table S1. All rates are in units of day−1.
aOnly these parameters were affected by assumptions around infant infectiousness, being estimated under the assumption that βInfant = k × βDisrupt for k in the range 0–1.
Table 2. Simulated incidence of hospital-acquired (HA) and community-acquired (CA) CDIs, under-reporting of cases and classification errors for two different
simulated classification schemes
Actual Proportion of
all reported cases %
IDSA/SHEA recommendations Lessa et al., classification
Proportion
reported %
Proportion of all
reported cases % b
Precision
%
Sensitivity
%
Proportion of all
reported cases % c
Precision
%
Sensitivity
%
Any HA 67 (66–70) 15 (9–23) 38 (38–39) 37 (24–57) 97 (96–97) 41 34 (22–53) 94 (93–95)
Any CA 35 (33–40) 85 (77–91) 57 (56–57) 99 (99–100) 65 (61–72) 59 99 (97–99) 68 (64–74)
HO-HA 100a 11 (7–17) 25 (25–25) 44 (29–65) 97 (96–97) 23 46 (31–67) 93 (91–94)
HO-CA 100a 17 (11–21) 3 (3–3) 89 (77–94) 15 (14–19) 5 85 (70–92) 27 (25–33)
CO-HA 31 (28–37) 3 (2–6) 13 (13–14) 24 (15–42) 96 (95–97) 18 18 (11–33) 99 (99–99)
CO-CA 30 (27–36) 69 (66–70) 54 (53–54) >99.8 78 (76–81) 53 >99.8 78 (76–81)
HA, hospital-acquired, CA, community-acquired, HO, hospital-onset, CO, community-onset.
The range in parenthesis is the range across all sensitivity analysis scenarios. Classification sensitivity is amongst reported cases only; thus, multiplying by the reported proportion will return
the sensitivity amongst all cases.
aWe assumed that all hospital-onset infections are reported.
bPercentages do not sum to 100% as some cases are classified as ‘indeterminate’ under this system.
cThe model was fit to estimates of CDI incidence that used this scheme to classify the location of acquisition. Consequently, these values change very little across the sensitivity analysis
scenarios.
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of hospital-onset and 19.6% (range: 19.4–20.3%) of reported
community-onset infections as hospital-acquired. A 7.4-day cut-off
(range: 5.0–9.5) for recent hospital admission (in hospital-onset
cases) and a 2.1-day cut-off (range: 1.3–3.9) for prior hospital dis-
charge were the optimal pair of cut-offs. A 6.6-day cut-off (range:
5.8–7.0) for recent hospital admission and a 12.5-day cut-off
(range: 11.8–14.5) for prior hospital discharge were the balanced
pair of cut-offs. The optimal cut-off correctly estimated the propor-
tion of cases that were hospital- or community-acquired, but had
poor precision (≈50%) to identify hospital-acquired cases (Fig. 5).
Discussion
Under all reasonable scenarios and modelling assumptions, trans-
mission between hospitalised adults amplified disease burden
(higher force of colonisation and higher colonisation proportion
in discharged patients than the general population) but was not
the key driver of toxigenic C. difficile transmission in the popula-
tion (hospital reproduction number less than one), in agreement
with previous modelling studies [19, 28]. When we simultaneously
assumed low prevalence of C. difficile colonisation in adults, no
infant infectiousness and no transmission from non-human
sources, the reproduction number in the community was also
less than one. In this unlikely scenario, the movement of colonised
individuals between hospital and community was essential for
persistence of C. difficile in both settings. However, in all other
scenarios without transmission from non-human sources, the
reproduction number was greater than one in the community,
and therefore transmission in the community would persist even
in the absence of transmission in hospitals. This is the first time
reproduction numbers have been estimated for C. difficile in a
model including both the hospital and the community.
Symptomatic carriers ofC. difficile accounted for <10% of trans-
mission in the community in our model. Despite accounting for
<2% of the total population, infants under 12 months accounted
for 17% of transmission in the community for our conservative
default assumptions and ⩾40% of transmission if infants were at
least as infectious as symptomatic adults and colonisation preva-
lence was ⩽5% in the community. However, the exact proportion
was highly sensitive to the relative infectiousness of infants
(which has not been well quantified) and the colonisation preva-
lence in adults in the community (which varies considerably
between studies and settings [13]). Nevertheless, our results indicate
that asymptomatically colonised infants are likely to be a substantial
source of transmission in the community. This is in agreement with
a number of small studies that found CDI was associated with
exposure to infants [29, 30] and a large study that, despite sampling
only 1% of infants in Oxfordshire, was able to determine that 2% of
all known CDIs in Oxfordshire could be reasonably attributed to
recent direct or indirect transmission from these infants [31].
We investigated how transmission from non-human sources
affected estimates of the reproduction number for person-to-
person transmission. We demonstrated that the reproduction
number in the human population was less than one if over 3.5–
26.0% of transmission in the community was from non-human
sources such as food or water contaminated by livestock animals.
If current transmission from animals is above this threshold,
C. difficile could not persist in the human population without
these non-human exposures. This animal-driven threshold in
terms of C. difficile exposures per person per year was remarkably
low: equivalent to one exposure leading to colonisation per adult
every 21.7 years under our default assumptions. For comparison,
it has been estimated that Australians have an episode of food-
borne gastroenteritis (i.e. not counting asymptomatic exposure)
on average once every 5 years [32]. Given the overlap of strains
between animals and humans, the presence of C. difficile spores
on raw meats and fresh vegetables [11], and the high survival
rate of C. difficile spores following cooking at recommended
‘safe’ temperatures [33], it is plausible that exposure exceeds this
low threshold. Though our model has not accounted for multiple
strains of C. difficile, one could apply the animal-driven threshold
to individual strains or types of C. difficile. For instance, it is not
plausible that ribotype 001, which accounts for a substantial pro-
portion of human cases but is not common in food animals [34],
exceeds the animal-driven threshold. On the other hand, it is
plausible that ribotypes 078, 027 and other ribotypes that both
cause human infection and are commonly isolated from animals
[34], exceed the threshold. This is especially true for ribotype 078,
as isolates from humans and food animals appear to be closely
related [12].
Fig. 5. Classification of the origin of reported CDIs by time since hospital discharge or admission, comparing the actual incidence of reported hospital-acquired
(HA) and community-acquired (CA) CDIs vs. the classification recommended by IDSA and SHEA and three variants. Lessa et al. use a 3-day cut-off for recent hospital
admission and a 12-week cut-off for recent hospital discharge. The optimal and balanced classifications we have identified use 7.4- and 6.6-day cut-offs, respect-
ively, for recent hospital admission and 2.1- and 12.5-day cut-offs, respectively, for recent hospital discharge.
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We estimate that approximately 70% of community-onset cases
are not reported, either because the patient does not seek treatment,
or the pathogen remains unidentified. This is in agreement with the
low treatment-seeking rates reported generally for diarrhoea [5, 25]
and low testing rates for C. difficile in primary care [6]. The simu-
lated proportion of community-acquired cases was higher amongst
community-onset cases than hospital-onset cases. Consequently,
we estimate that while two-thirds of hospital-acquired infections
are reported, only one-third of community-acquired infections
are reported. Though we only simulated the under-reporting of
community-onset cases, our findings complement an empirical
study that found that missed cases of CDI in hospital settings
are disproportionately likely to be community-acquired [35].
Existing classification schemes attempt to account for cases that
may acquire the pathogen in one setting and, after an incubation
period, develop symptoms in another; however, these schemes
are highly asymmetric with regards to setting [3, 14]. While only
hospital-onset cases with symptom onset within 2 or 3 days of
hospital admission are considered community-acquired, all
community-onset cases with symptom onset within 4 or 12
weeks of hospital discharge are classified as hospital-acquired.
Empirical estimates of the median incubation period vary consid-
erably from 18 to 33 days [36] but lie between the two extremes of
these cut-offs. Therefore, it is likely that typical cut-offs for classi-
fying hospital-onset cases as community-acquired are too short
and typical cut-offs for classifying community-onset infections as
hospital-acquired are too long. We confirmed this with our
model by demonstrating that, to balance the sensitivity and speci-
ficity of classification, these cut-offs should be approximately 6 and
12 days, respectively. We also demonstrated that any scheme based
on time sincemost recent hospital discharge cannot adequately dis-
tinguish hospital- and community-acquired cases. Even our
balanced scheme had very poor precision for hospital-acquired
cases: half or more of all cases classified as hospital-acquired
were actually community-acquired. This can be understood by not-
ing that the mean length of hospital stay (between 4 and 10 days
in most high-income countries [37]) is short compared with the
duration of colonisation, which may be several weeks [38].
Consequently, more than 60% of patients who were colonised at
hospital discharge in our model were not exposed in the preceding
hospitalisation, but rather in the community prior to admission.
Therefore, even patients who developed CDI very soon after hos-
pital discharge were more likely to be community-acquired than
hospital-acquired. Adjusting the cut-off times cannot correct this
flaw in the existing classification schemes. Alternative schemes,
such as classification based on the total number of days spent in
hospital in the weeks leading up to the onset of symptoms, should
be considered. Our model demonstrates that the classification
scheme recommended by IDSA and SHEA has very high sensitivity
for hospital-acquired cases, and therefore may be useful if all
hospital-acquired cases need to be identified or excluded.
However, the asymmetry and unrealistic timescales in existing clas-
sification schemes inadvertently reinforce the a priori assumptions
upon which they are based: that the colonisation pressure in hospi-
tals far exceeds the colonisation pressure in the community.
Our study has several limitations. The data used to fit the
model were incomplete and were gathered from many different
sources, countries and settings. In particular, the published esti-
mates of colonisation prevalence vary significantly between stud-
ies and it is unclear to what extent this reflects genuine differences
between study populations or variations associated with different
detection methods or small sample sizes [13]. We addressed this
by considering a range of scenarios that reflected the possible
range of colonisation prevalence. The relative infectiousness of
infants and adults is also unknown, so we allowed the relative
infectiousness of infants and adults to vary in our sensitivity ana-
lysis but were therefore unable to provide a precise estimate of the
amount of transmission attributable to infants. However, our
broad sensitivity analysis and wide variety of input data improve
the global applicability of the model. National estimates in the
USA suggest that nearly all people with CDI had received some
form of healthcare soon before onset of symptoms if outpatient
and primary care were included [3]. This does not imply that
most CDIs are healthcare-acquired, since antibiotic exposure is
a causative factor for CDI and antibiotics are prescription-only
medicines in many countries, including the USA. However, we
were unable to model pathogen acquisition from other sources
of healthcare, because the hospital in our model consisted only
of admitted patients, with the community including patients
receiving all other forms of healthcare (including residents of
long-term care facilities). Long-term care facilities contain sub-
populations of individuals at high risk for CDI [3]. As we have
not modelled long-term care facilities separately, we are likely to
have underestimated the heterogeneity and thus the reproduction
number in the community. The model population is well-mixed
and does not capture heterogeneity in hospital admission rates
or heterogeneity in the contact rates of infants, adults and the eld-
erly, which may also affect reproduction number estimates.
Finally, we did not differentiate between the many strains of
C. difficile [39], so it is possible the hospital reproduction
numbers, community reproduction numbers and animal-driven
thresholds differ by strain.
Under-reporting of community-onset CDIs and the misclassi-
fication of many community-acquired infections obscure and
underestimate the extent of transmission in the community. It
seems likely that unreported community-onset cases will be less
severe and that the classification (or misclassification) of individ-
ual cases as hospital-acquired or community-acquired will not
affect the treatment or outcomes of patients. Therefore, at the
level of individual cases, even large-scale under-reporting and
misclassification may not be very harmful if those with severe dis-
ease receive appropriate care. However, to prevent infections, we
must understand when, where and how transmission occurs at
the level of the population. We have demonstrated that most
infections (hospital-onset and community-onset alike) are
acquired outside of hospitals, but only a small fraction are
reported. Therefore, interventions that prevent acquisition outside
hospitals, or prevent patients admitted with asymptomatic
colonisation from developing symptoms should be considered
and assessed. Merely reducing transmission between hospitalised
patients will not be sufficient to prevent the spread of this
important pathogen. Further investigation into the relative infec-
tiousness of infants is required before the proportion of transmis-
sion from infants can be estimated. However, we have
demonstrated that a high degree of transmission from infants is
consistent with available data on spore shedding [8] and colonisa-
tion prevalence [8, 9]. Similarly, though the frequency of food and
animal-to-human transmission is unknown for C. difficile, we
have demonstrated that even very modest and plausible frequen-
cies of exposure may imply that C. difficile is sustained in
human populations by transmission from animals or contami-
nated food. If this is the case, C. difficile can be eradicated from
the human population if and only if animal-to-human transmis-
sion is reduced.
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